TermID	Term	Enrichment	logP	Genes in Term	Target Genes in Term	Fraction of Targets in Term	Total Target Genes	Total Genes	Entrez Gene IDs	Gene Symbols
HUMAN_PROSYN-PWY	proline biosynthesis	0.00251903882241108	-5.98387786989593	2	2	0.0434782608695652	46	907	5832,5831	ALDH18A1,PYCR1
META_PROSYN-PWY	L-proline biosynthesis I	0.00251903882241108	-5.98387786989593	2	2	0.0434782608695652	46	907	5832,5831	ALDH18A1,PYCR1
HUMAN_PWY66-409	superpathway of purine nucleotide salvage	0.00981569175383516	-4.62377297448762	38	6	0.130434782608696	46	907	353,3251,3615,204,29922,132	APRT,HPRT1,IMPDH2,AK2,NME7,ADK
HUMAN_PWY-5667	CDP-diacylglycerol biosynthesis	0.0128256020429909	-4.35631194610382	19	4	0.0869565217391304	46	907	10162,253558,56895,84803	LPCAT3,LCLAT1,AGPAT4,GPAT3
META_POLYAMINSYN3-PWY	superpathway of polyamine biosynthesis II	0.0141519288212456	-4.25790435172707	4	2	0.0434782608695652	46	907	6723,4953	SRM,ODC1
HUMAN_PWY-5695	urate biosynthesis/inosine 5'-phosphate degradation	0.0228272359437164	-3.77980089700465	5	2	0.0434782608695652	46	907	3615,4907	IMPDH2,NT5E
META_PWY-841	superpathway of purine nucleotides de novo biosynthesis I	0.0244257390584198	-3.71211782323389	13	3	0.0652173913043478	46	907	2618,3615,471	GART,IMPDH2,ATIC
META_PWY66-409	superpathway of purine nucleotide salvage	0.0244257390584198	-3.71211782323389	13	3	0.0652173913043478	46	907	3251,3615,132	HPRT1,IMPDH2,ADK
META_PWY-5695	urate biosynthesis/inosine 5'-phosphate degradation	0.03314238770518	-3.4069422205393	6	2	0.0434782608695652	46	907	3615,4907	IMPDH2,NT5E
HUMAN_TRIGLSYN-PWY	triacylglycerol biosynthesis	0.0334579015212923	-3.39746730143047	25	4	0.0869565217391304	46	907	10162,253558,56895,84803	LPCAT3,LCLAT1,AGPAT4,GPAT3
HUMAN_PWY-841	purine nucleotides de novo biosynthesis	0.03454208051879	-3.36557697302294	37	5	0.108695652173913	46	907	3615,2618,204,29922,471	IMPDH2,GART,AK2,NME7,ATIC
HUMAN_P121-PWY	adenine and adenosine salvage I	0.050716648291178	-2.9815010536239	1	1	0.0217391304347826	46	907	353	APRT
META_PWY-46	putrescine biosynthesis III	0.050716648291178	-2.9815010536239	1	1	0.0217391304347826	46	907	4953	ODC1
META_PWY-6619	adenine and adenosine salvage VI	0.050716648291178	-2.9815010536239	1	1	0.0217391304347826	46	907	132	ADK
HUMAN_PWY66-366	flavin biosynthesis	0.050716648291178	-2.9815010536239	1	1	0.0217391304347826	46	907	80308	FLAD1
HUMAN_BSUBPOLYAMSYN-PWY	spermidine biosynthesis	0.050716648291178	-2.9815010536239	1	1	0.0217391304347826	46	907	6723	SRM
HUMAN_PWY-46	putrescine biosynthesis I	0.050716648291178	-2.9815010536239	1	1	0.0217391304347826	46	907	4953	ODC1
HUMAN_PWY-6619	adenine and adenosine salvage II	0.050716648291178	-2.9815010536239	1	1	0.0217391304347826	46	907	132	ADK
META_BSUBPOLYAMSYN-PWY	spermidine biosynthesis I	0.050716648291178	-2.9815010536239	1	1	0.0217391304347826	46	907	6723	SRM
HUMAN_PWY-6353	purine nucleotides degradation	0.0721805619574741	-2.62858449429664	9	2	0.0434782608695652	46	907	3615,4907	IMPDH2,NT5E
META_PWY-6353	purine nucleotides degradation II (aerobic)	0.0721805619574741	-2.62858449429664	9	2	0.0434782608695652	46	907	3615,4907	IMPDH2,NT5E
META_PWY-6620	guanine and guanosine salvage	0.0989142577581856	-2.31350188736499	2	1	0.0217391304347826	46	907	3251	HPRT1
HUMAN_PWY-6121	5-aminoimidazole ribonucleotide biosynthesis	0.0989142577581856	-2.31350188736499	2	1	0.0217391304347826	46	907	2618	GART
META_PWY-6613	tetrahydrofolate salvage from 5,10-methenyltetrahydrofolate	0.0989142577581856	-2.31350188736499	2	1	0.0217391304347826	46	907	2618	GART
META_PWY0-1295	pyrimidine ribonucleosides degradation	0.0989142577581856	-2.31350188736499	2	1	0.0217391304347826	46	907	7378	UPP1
META_PWY66-366	flavin biosynthesis IV (mammalian)	0.0989142577581856	-2.31350188736499	2	1	0.0217391304347826	46	907	80308	FLAD1
HUMAN_PWY-7286	7-(3-amino-3-carboxypropyl)-wyosine biosynthesis	0.0989142577581856	-2.31350188736499	2	1	0.0217391304347826	46	907	55253	TYW1
META_PWY-6121	5-aminoimidazole ribonucleotide biosynthesis I	0.0989142577581856	-2.31350188736499	2	1	0.0217391304347826	46	907	2618	GART
HUMAN_PWY-6620	guanine and guanosine salvage	0.0989142577581856	-2.31350188736499	2	1	0.0217391304347826	46	907	3251	HPRT1
HUMAN_GLUTAMINDEG-PWY	glutamine degradation/glutamate biosynthesis	0.0989142577581856	-2.31350188736499	2	1	0.0217391304347826	46	907	2744	GLS
META_PWY-6124	inosine-5'-phosphate biosynthesis II	0.0989142577581856	-2.31350188736499	2	1	0.0217391304347826	46	907	471	ATIC
META_SER-GLYSYN-PWY	superpathway of L-serine and glycine biosynthesis I	0.0989142577581856	-2.31350188736499	2	1	0.0217391304347826	46	907	6472	SHMT2
HUMAN_PWY-6124	inosine-5'-phosphate biosynthesis	0.0989142577581856	-2.31350188736499	2	1	0.0217391304347826	46	907	471	ATIC
HUMAN_PWY-6613	tetrahydrofolate salvage from 5,10-methenyltetrahydrofolate	0.0989142577581856	-2.31350188736499	2	1	0.0217391304347826	46	907	2618	GART
HUMAN_PWY-5670	epoxysqualene biosynthesis	0.0989142577581856	-2.31350188736499	2	1	0.0217391304347826	46	907	6713	SQLE
HUMAN_PWY-6482	diphthamide biosynthesis	0.0989142577581856	-2.31350188736499	2	1	0.0217391304347826	46	907	89978	DPH6
META_PWY-5670	epoxysqualene biosynthesis	0.0989142577581856	-2.31350188736499	2	1	0.0217391304347826	46	907	6713	SQLE
HUMAN_GLYSYN-PWY	glycine/serine biosynthesis	0.0989142577581856	-2.31350188736499	2	1	0.0217391304347826	46	907	6472	SHMT2
HUMAN_ASPARAGINE-BIOSYNTHESIS	asparagine biosynthesis	0.0989142577581856	-2.31350188736499	2	1	0.0217391304347826	46	907	440	ASNS
META_PWY66-341	cholesterol biosynthesis I	0.103425163145956	-2.26890698920341	11	2	0.0434782608695652	46	907	6713,1717	SQLE,DHCR7
META_PWY66-4	cholesterol biosynthesis III (via desmosterol)	0.103425163145956	-2.26890698920341	11	2	0.0434782608695652	46	907	6713,1717	SQLE,DHCR7
HUMAN_PWY-7221	guanosine ribonucleotides de novo biosynthesis	0.103425163145956	-2.26890698920341	11	2	0.0434782608695652	46	907	3615,29922	IMPDH2,NME7
META_PWY-6363	D-myo-inositol (1,4,5)-trisphosphate degradation	0.103425163145956	-2.26890698920341	11	2	0.0434782608695652	46	907	8871,8867	SYNJ2,SYNJ1
META_PWY66-3	cholesterol biosynthesis II (via 24,25-dihydrolanosterol)	0.103425163145956	-2.26890698920341	11	2	0.0434782608695652	46	907	6713,1717	SQLE,DHCR7
HUMAN_LIPAS-PWY	triacylglycerol degradation	0.103425163145956	-2.26890698920341	11	2	0.0434782608695652	46	907	11343,57406	MGLL,ABHD6
META_PWY66-5	superpathway of cholesterol biosynthesis	0.106202316961702	-2.24240935344711	23	3	0.0652173913043478	46	907	6713,3422,1717	SQLE,IDI1,DHCR7
META_PWY-6857	retinol biosynthesis	0.120215589305843	-2.11846857056651	12	2	0.0434782608695652	46	907	5947,157506	RBP1,RDH10
HUMAN_PWY66-5	superpathway of cholesterol biosynthesis	0.128627133801442	-2.0508374956443	25	3	0.0652173913043478	46	907	6713,3422,1717	SQLE,IDI1,DHCR7
HUMAN_PWY66-4	cholesterol biosynthesis III (via desmosterol)	0.137631925714618	-1.98317236212013	13	2	0.0434782608695652	46	907	6713,1717	SQLE,DHCR7
HUMAN_PWY66-341	cholesterol biosynthesis I	0.137631925714618	-1.98317236212013	13	2	0.0434782608695652	46	907	6713,1717	SQLE,DHCR7
HUMAN_PWY66-3	cholesterol biosynthesis II (via 24,25-dihydrolanosterol)	0.137631925714618	-1.98317236212013	13	2	0.0434782608695652	46	907	6713,1717	SQLE,DHCR7
META_PWY-6861	the visual cycle I (vertebrates)	0.137631925714618	-1.98317236212013	13	2	0.0434782608695652	46	907	5947,157506	RBP1,RDH10
HUMAN_PWY-6363	D-myo-inositol (1,4,5)-trisphosphate degradation	0.137631925714618	-1.98317236212013	13	2	0.0434782608695652	46	907	8871,8867	SYNJ2,SYNJ1
META_PWY-6609	adenine and adenosine salvage III	0.144715301011669	-1.93298690793807	3	1	0.0217391304347826	46	907	3251	HPRT1
META_ARGININE-SYN4-PWY	L-ornithine de novo  biosynthesis	0.144715301011669	-1.93298690793807	3	1	0.0217391304347826	46	907	5832	ALDH18A1
HUMAN_PWY0-1295	pyrimidine ribonucleosides degradation	0.144715301011669	-1.93298690793807	3	1	0.0217391304347826	46	907	7378	UPP1
HUMAN_PWY-6875	retinoate biosynthesis II	0.144715301011669	-1.93298690793807	3	1	0.0217391304347826	46	907	5947	RBP1
HUMAN_OXIDATIVEPENT-PWY-1	pentose phosphate pathway (oxidative branch)	0.144715301011669	-1.93298690793807	3	1	0.0217391304347826	46	907	5226	PGD
META_PWY-6875	retinoate biosynthesis II	0.144715301011669	-1.93298690793807	3	1	0.0217391304347826	46	907	5947	RBP1
HUMAN_PWY66-385	dTMP de novo biosynthesis (mitochondrial)	0.144715301011669	-1.93298690793807	3	1	0.0217391304347826	46	907	6472	SHMT2
META_PWY-7527	L-methionine salvage cycle III	0.144715301011669	-1.93298690793807	3	1	0.0217391304347826	46	907	6723	SRM
META_PWY66-425	L-lysine degradation II (L-pipecolate pathway)	0.144715301011669	-1.93298690793807	3	1	0.0217391304347826	46	907	5831	PYCR1
META_OXIDATIVEPENT-PWY	pentose phosphate pathway (oxidative branch)	0.144715301011669	-1.93298690793807	3	1	0.0217391304347826	46	907	5226	PGD
HUMAN_PWY-6609	adenine and adenosine salvage III	0.144715301011669	-1.93298690793807	3	1	0.0217391304347826	46	907	3251	HPRT1
HUMAN_ARGININE-SYN4-PWY	ornithine de novo  biosynthesis	0.144715301011669	-1.93298690793807	3	1	0.0217391304347826	46	907	5832	ALDH18A1
HUMAN_PWY0-1264	biotin-carboxyl carrier protein assembly	0.144715301011669	-1.93298690793807	3	1	0.0217391304347826	46	907	3141	HLCS
HUMAN_PWY-7283	wybutosine biosynthesis	0.144715301011669	-1.93298690793807	3	1	0.0217391304347826	46	907	55253	TYW1
HUMAN_PWY-7228	guanosine nucleotides de novo biosynthesis	0.155571011966885	-1.86065298300689	14	2	0.0434782608695652	46	907	3615,29922	IMPDH2,NME7
HUMAN_PWY-6861	the visual cycle I (vertebrates)	0.173938139126683	-1.74905556524107	15	2	0.0434782608695652	46	907	5947,157506	RBP1,RDH10
HUMAN_PWY-6362	1D-myo-inositol hexakisphosphate biosynthesis II (mammalian)	0.173938139126683	-1.74905556524107	15	2	0.0434782608695652	46	907	8871,8867	SYNJ2,SYNJ1
META_PWY-6362	1D-myo-inositol hexakisphosphate biosynthesis II (mammalian)	0.173938139126683	-1.74905556524107	15	2	0.0434782608695652	46	907	8871,8867	SYNJ2,SYNJ1
HUMAN_PWY-6364	D-myo-inositol (1,3,4)-trisphosphate biosynthesis	0.173938139126683	-1.74905556524107	15	2	0.0434782608695652	46	907	8871,8867	SYNJ2,SYNJ1
META_PWY-6364	D-myo-inositol (1,3,4)-trisphosphate biosynthesis	0.173938139126683	-1.74905556524107	15	2	0.0434782608695652	46	907	8871,8867	SYNJ2,SYNJ1
META_PWY-6823	molybdenum cofactor biosynthesis	0.18823642507533	-1.67005652605589	4	1	0.0217391304347826	46	907	10243	GPHN
META_PWY-5189	tetrapyrrole biosynthesis II (from glycine)	0.18823642507533	-1.67005652605589	4	1	0.0217391304347826	46	907	210	ALAD
META_PWY-7434	terminal O-glycans residues modification	0.18823642507533	-1.67005652605589	4	1	0.0217391304347826	46	907	2651	GCNT2
HUMAN_PWY-5123	trans, trans-farnesyl diphosphate biosynthesis	0.18823642507533	-1.67005652605589	4	1	0.0217391304347826	46	907	3422	IDI1
HUMAN_PWY-2161	folate polyglutamylation	0.18823642507533	-1.67005652605589	4	1	0.0217391304347826	46	907	6472	SHMT2
META_PWY-5123	trans, trans-farnesyl diphosphate biosynthesis	0.18823642507533	-1.67005652605589	4	1	0.0217391304347826	46	907	3422	IDI1
META_PWY-7181	pyrimidine deoxyribonucleosides degradation	0.18823642507533	-1.67005652605589	4	1	0.0217391304347826	46	907	7378	UPP1
HUMAN_SER-GLYSYN-PWY	serine and glycine biosynthesis	0.18823642507533	-1.67005652605589	4	1	0.0217391304347826	46	907	6472	SHMT2
HUMAN_PWY-5874	heme degradation	0.18823642507533	-1.67005652605589	4	1	0.0217391304347826	46	907	3163	HMOX2
HUMAN_PWY-5189	tetrapyrrole biosynthesis	0.18823642507533	-1.67005652605589	4	1	0.0217391304347826	46	907	210	ALAD
HUMAN_PWY-6823	molybdenum cofactor biosynthesis	0.18823642507533	-1.67005652605589	4	1	0.0217391304347826	46	907	10243	GPHN
HUMAN_PWY66-425	lysine degradation II (pipecolate pathway)	0.18823642507533	-1.67005652605589	4	1	0.0217391304347826	46	907	5831	PYCR1
HUMAN_PWY-6857	retinol biosynthesis	0.211616599254077	-1.55297913569442	17	2	0.0434782608695652	46	907	5947,157506	RBP1,RDH10
META_PWY-5667	CDP-diacylglycerol biosynthesis I	0.229588722358393	-1.4714657343912	5	1	0.0217391304347826	46	907	56895	AGPAT4
HUMAN_PWY-7181	pyrimidine deoxyribonucleosides degradation	0.229588722358393	-1.4714657343912	5	1	0.0217391304347826	46	907	7378	UPP1
HUMAN_PWY66-375	leukotriene biosynthesis	0.229588722358393	-1.4714657343912	5	1	0.0217391304347826	46	907	1800	DPEP1
HUMAN_PWY-3661-1	glycine betaine degradation	0.229588722358393	-1.4714657343912	5	1	0.0217391304347826	46	907	6472	SHMT2
META_CITRULBIO-PWY	L-citrulline biosynthesis	0.229588722358393	-1.4714657343912	5	1	0.0217391304347826	46	907	5832	ALDH18A1
META_PWY66-375	leukotriene biosynthesis	0.229588722358393	-1.4714657343912	5	1	0.0217391304347826	46	907	1800	DPEP1
META_PWY-3661-1	glycine betaine degradation II (mammalian)	0.229588722358393	-1.4714657343912	5	1	0.0217391304347826	46	907	6472	SHMT2
META_SALVADEHYPOX-PWY	adenosine nucleotides degradation II	0.229588722358393	-1.4714657343912	5	1	0.0217391304347826	46	907	4907	NT5E
META_PWY-7209	superpathway of pyrimidine ribonucleosides degradation	0.229588722358393	-1.4714657343912	5	1	0.0217391304347826	46	907	7378	UPP1
META_PWY-6368	3-phosphoinositide degradation	0.250058129076704	-1.3860618718408	19	2	0.0434782608695652	46	907	8871,8867	SYNJ2,SYNJ1
META_PWY-6358	superpathway of D-myo-inositol (1,4,5)-trisphosphate metabolism	0.250058129076704	-1.3860618718408	19	2	0.0434782608695652	46	907	8871,8867	SYNJ2,SYNJ1
META_PWY-7221	guanosine ribonucleotides de novo biosynthesis	0.268877989289591	-1.31349757368909	6	1	0.0217391304347826	46	907	3615	IMPDH2
HUMAN_PENTOSE-P-PWY	pentose phosphate pathway	0.268877989289591	-1.31349757368909	6	1	0.0217391304347826	46	907	5226	PGD
HUMAN_PWY-7209	pyrimidine ribonucleosides degradation	0.268877989289591	-1.31349757368909	6	1	0.0217391304347826	46	907	7378	UPP1
HUMAN_PWY-6358	superpathway of D-myo-inositol (1,4,5)-trisphosphate metabolism	0.269403109180763	-1.31154647394121	20	2	0.0434782608695652	46	907	8871,8867	SYNJ2,SYNJ1
HUMAN_PWY-6368	3-phosphoinositide degradation	0.269403109180763	-1.31154647394121	20	2	0.0434782608695652	46	907	8871,8867	SYNJ2,SYNJ1
META_PWY-5920	superpathway of heme biosynthesis from glycine	0.306204973188695	-1.18350055425526	7	1	0.0217391304347826	46	907	210	ALAD
HUMAN_PWY66-374	C20 prostanoid biosynthesis	0.306204973188695	-1.18350055425526	7	1	0.0217391304347826	46	907	6916	TBXAS1
META_PWY-6872	retinoate biosynthesis I	0.306204973188695	-1.18350055425526	7	1	0.0217391304347826	46	907	5947	RBP1
HUMAN_SALVADEHYPOX-PWY	adenosine nucleotides degradation	0.306204973188695	-1.18350055425526	7	1	0.0217391304347826	46	907	4907	NT5E
META_PWY66-374	C20 prostanoid biosynthesis	0.306204973188695	-1.18350055425526	7	1	0.0217391304347826	46	907	6916	TBXAS1
HUMAN_PWY66-414	superpathway of choline degradation to L-serine	0.306204973188695	-1.18350055425526	7	1	0.0217391304347826	46	907	6472	SHMT2
HUMAN_PWY-5920	heme biosynthesis	0.306204973188695	-1.18350055425526	7	1	0.0217391304347826	46	907	210	ALAD
HUMAN_PWY-7434	terminal O-glycans residues modification	0.341665607892771	-1.07392277493297	8	1	0.0217391304347826	46	907	2651	GCNT2
HUMAN_PWY-2201	folate transformations I	0.341665607892771	-1.07392277493297	8	1	0.0217391304347826	46	907	6472	SHMT2
HUMAN_PWY-6872	retinoate biosynthesis I	0.341665607892771	-1.07392277493297	8	1	0.0217391304347826	46	907	5947	RBP1
META_PWY-7228	superpathway of guanosine nucleotides de novo biosynthesis I	0.341665607892771	-1.07392277493297	8	1	0.0217391304347826	46	907	3615	IMPDH2
META_PWY-6367	D-myo-inositol-5-phosphate metabolism	0.375351238635322	-0.979893055020996	9	1	0.0217391304347826	46	907	5305	PIP4K2A
HUMAN_PWY-7205	CMP phosphorylation	0.375351238635322	-0.979893055020996	9	1	0.0217391304347826	46	907	29922	NME7
HUMAN_PWY-7527	methionine salvage cycle III	0.375351238635322	-0.979893055020996	9	1	0.0217391304347826	46	907	6723	SRM
META_PWY-922	mevalonate pathway I	0.407348836657031	-0.89808536811018	10	1	0.0217391304347826	46	907	3422	IDI1
HUMAN_PWY-7227	adenosine deoxyribonucleotides de novo biosynthesis	0.407348836657031	-0.89808536811018	10	1	0.0217391304347826	46	907	29922	NME7
HUMAN_PWY-922	mevalonate pathway	0.407348836657031	-0.89808536811018	10	1	0.0217391304347826	46	907	3422	IDI1
HUMAN_PWY-7226	guanosine deoxyribonucleotides de novo biosynthesis	0.407348836657031	-0.89808536811018	10	1	0.0217391304347826	46	907	29922	NME7
HUMAN_PWY-7197	pyrimidine deoxyribonucleotide phosphorylation	0.407348836657031	-0.89808536811018	10	1	0.0217391304347826	46	907	29922	NME7
META_PWY-5004	superpathway of L-citrulline metabolism	0.437741204008244	-0.826127401659988	11	1	0.0217391304347826	46	907	5832	ALDH18A1
HUMAN_PWY-7224	purine deoxyribonucleosides salvage	0.437741204008244	-0.826127401659988	11	1	0.0217391304347826	46	907	29922	NME7
HUMAN_PWY-7176	UTP and CTP de novo biosynthesis	0.437741204008244	-0.826127401659988	11	1	0.0217391304347826	46	907	29922	NME7
META_PWY66-391	fatty acid beta-oxidation VI (peroxisome)	0.466607168982047	-0.762267555213551	12	1	0.0217391304347826	46	907	51	ACOX1
HUMAN_PWY-5910	superpathway of geranylgeranyldiphosphate biosynthesis I (via mevalonate)	0.466607168982047	-0.762267555213551	12	1	0.0217391304347826	46	907	3422	IDI1
META_PWY-5910	superpathway of geranylgeranyldiphosphate biosynthesis I (via mevalonate)	0.466607168982047	-0.762267555213551	12	1	0.0217391304347826	46	907	3422	IDI1
HUMAN_PWY0-162	superpathway of pyrimidine ribonucleotides de novo biosynthesis	0.494021772588111	-0.705175688700445	13	1	0.0217391304347826	46	907	29922	NME7
META_PWY-6351	D-myo-inositol (1,4,5)-trisphosphate biosynthesis	0.494021772588111	-0.705175688700445	13	1	0.0217391304347826	46	907	5305	PIP4K2A
HUMAN_PWY66-391	fatty acid beta-oxidation (peroxisome)	0.494021772588111	-0.705175688700445	13	1	0.0217391304347826	46	907	51	ACOX1
HUMAN_PWY-7184	pyrimidine deoxyribonucleotides de novo biosynthesis	0.520056446481985	-0.653817922370996	14	1	0.0217391304347826	46	907	29922	NME7
HUMAN_PWY-7210	pyrimidine deoxyribonucleotides biosynthesis from CTP	0.520056446481985	-0.653817922370996	14	1	0.0217391304347826	46	907	29922	NME7
HUMAN_PWY-7200	superpathway of pyrimidine deoxyribonucleoside salvage	0.544779182722982	-0.607374735737787	15	1	0.0217391304347826	46	907	29922	NME7
HUMAN_PWY-6367	D-myo-inositol-5-phosphate metabolism	0.590544576752479	-0.526710156350617	17	1	0.0217391304347826	46	907	5305	PIP4K2A
HUMAN_PWY-4061	glutathione-mediated detoxification	0.631799069784376	-0.459183862941327	19	1	0.0217391304347826	46	907	4257	MGST1
HUMAN_PWY-7219	adenosine ribonucleotides de novo biosynthesis	0.631799069784376	-0.459183862941327	19	1	0.0217391304347826	46	907	204	AK2
HUMAN_PWY-7211	superpathway of pyrimidine deoxyribonucleotides de novo biosynthesis	0.650872541395683	-0.42944144488945	20	1	0.0217391304347826	46	907	29922	NME7
HUMAN_PWY-6371	superpathway of inositol phosphate compounds	0.666774484056656	-0.405303395099434	66	3	0.0652173913043478	46	907	8871,8867,5305	SYNJ2,SYNJ1,PIP4K2A
HUMAN_PWY-6351	D-myo-inositol (1,4,5)-trisphosphate biosynthesis	0.702476936372974	-0.35314270909898	23	1	0.0217391304347826	46	907	5305	PIP4K2A
HUMAN_PWY-7433	mucin core 1 and core 2 O-glycosylation	0.732651873287096	-0.311084624036435	25	1	0.0217391304347826	46	907	55568	GALNT10
HUMAN_LIPASYN-PWY	phospholipases	0.784292666842814	-0.242973028746263	29	1	0.0217391304347826	46	907	81579	PLA2G12A
HUMAN_PWY0-1313	acetate conversion to acetyl-CoA	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
HUMAN_PWY-6365	D-myo-inositol (3,4,5,6)-tetrakisphosphate biosynthesis	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
META_PWY-6076	vitamin D3 biosynthesis	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
HUMAN_PWY-6405	Rapoport-Luebering glycolytic shunt	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
META_CHOLINE-BETAINE-ANA-PWY	choline degradation I	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
HUMAN_PWY-6129	dolichol and dolichyl phosphate biosynthesis	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
HUMAN_PWY0-662	PRPP biosynthesis	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
HUMAN_PWY-6076	vitamin D3 biosynthesis	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
META_PWY-6117	spermine and spermidine degradation I	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
HUMAN_PWY-7179-1	purine deoxyribonucleosides degradation	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
HUMAN_GLYSYN-ALA-PWY	glycine biosynthesis	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
META_PWY-4041	gamma-glutamyl cycle	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
META_PWY66-394	aspirin triggered resolvin E biosynthesis	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
META_PWY66-397	resolvin D biosynthesis	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
META_PWY-5340	sulfate activation for sulfonation	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
META_PWY-7437	protein O-[N-acetyl]-glucosylation	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
HUMAN_PWY-6118	glycerol-3-phosphate shuttle	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
META_PWY-6688	thyronamine and iodothyronamine metabolism	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
HUMAN_PWY66-301	catecholamine biosynthesis	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
HUMAN_BETA-ALA-DEGRADATION-I-PWY	beta-alanine degradation	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
HUMAN_PWY-4821	UDP-D-xylose and UDP-D-glucuronate biosynthesis	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
META_PWY-6138	CMP-N-acetylneuraminate biosynthesis I (eukaryotes)	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
META_PWY-5874	heme degradation	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
HUMAN_PWY6666-1	anandamide degradation	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
META_PWY3O-4106	NAD salvage pathway III	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
META_PWY-6365	D-myo-inositol (3,4,5,6)-tetrakisphosphate biosynthesis	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
HUMAN_PWY-5905	hypusine biosynthesis	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
META_PWY-7511	protein ubiquitylation	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
META_PWY-6118	glycerol-3-phosphate shuttle	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
HUMAN_PWY-6370	ascorbate recycling (cytosolic)	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
HUMAN_PWY-5686	UMP biosynthesis	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
HUMAN_PWY66-397	resolvin D biosynthesis	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
HUMAN_PWY-6241	thyroid hormone biosynthesis	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
HUMAN_PWY-5525	D-glucuronate degradation	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
HUMAN_PWY-5481	lactate fermentation (reoxidation of cytosolic NADH)	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
HUMAN_PWY66-14	MAP kinase cascade	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
HUMAN_PWY-5340	sulfate activation for sulfonation	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
META_PLPSAL-PWY	pyridoxal 5'-phosphate salvage I	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
HUMAN_PWY-7437	protein O-[N-acetyl]-glucosylation	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
HUMAN_ASPARTATESYN-PWY	aspartate biosynthesis	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
HUMAN_PWY0-1275	lipoate biosynthesis and incorporation	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
META_PWY-5030	L-histidine degradation III	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
HUMAN_PWY-6688	thyronamine and iodothyronamine metabolism	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
HUMAN_PWY-5386	methylglyoxal degradation I	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
META_PWY-5806	all-trans-decaprenyl diphosphate biosynthesis	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
META_PWY66-395	aspirin triggered resolvin D biosynthesis	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
HUMAN_FASYN-ELONG-PWY	fatty acid elongation -- saturated	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
HUMAN_PWY66-393	aspirin-triggered lipoxin biosynthesis	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
HUMAN_PWY-4041	gamma-glutamyl cycle	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
META_LYSINE-DEG1-PWY	L-lysine degradation XI (mammalian)	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
HUMAN_PWY66-394	aspirin triggered resolvin E biosynthesis	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
HUMAN_PWY-6138	CMP-N-acetylneuraminate biosynthesis I (eukaryotes)	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
HUMAN_PWY66-395	aspirin triggered resolvin D biosynthesis	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
META_PWY66-380	estradiol biosynthesis I (via estrone)	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
HUMAN_PWY-6012-1	acyl carrier protein metabolism	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
HUMAN_CYSTEINE-DEG-PWY	L-cysteine degradation I	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
HUMAN_PWY-5269	cardiolipin biosynthesis	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
HUMAN_PWY-6181	histamine degradation	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
META_PWY0-662	PRPP biosynthesis I	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
META_PWY66-393	aspirin-triggered lipoxin biosynthesis	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
HUMAN_LYSINE-DEG1-PWY	lysine degradation I (saccharopine pathway)	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
META_PWY-5177	glutaryl-CoA degradation	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
META_SERDEG-PWY	L-serine degradation	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
META_GLUDEG-I-PWY	GABA shunt	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
META_PWY-6145	superpathway of sialic acids and CMP-sialic acids biosynthesis	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
HUMAN_PWY-6260	thyroid hormone metabolism I (via deiodination)	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
META_PWY-7179-1	purine deoxyribonucleosides degradation	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
META_PWY-6307	L-tryptophan degradation X (mammalian, via tryptamine)	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
META_PWY66-388	fatty acid alpha-oxidation III	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
META_PWY-5453	methylglyoxal degradation III	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
META_PWY-5505	L-glutamate and L-glutamine biosynthesis	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
META_PROUT-PWY	L-proline degradation	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
HUMAN_PWY-1801	formaldehyde oxidation	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
HUMAN_PWY-6	GDP-L-fucose biosynthesis II (from L-fucose)	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
HUMAN_PWY-5137	fatty acid beta-oxidation (unsaturated, odd number)	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
HUMAN_PWY-7306	estradiol biosynthesis II	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
META_PWY-7343	UDP-glucose biosynthesis	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
HUMAN_PWY-2301	myo-inositol de novo biosynthesis	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
HUMAN_CHOLINE-BETAINE-ANA-PWY	choline degradation	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
META_UDPNACETYLGALSYN-PWY	UDP-N-acetyl-D-glucosamine biosynthesis II	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
META_PWY-6260	thyroid hormone metabolism I (via deiodination)	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
META_PWY-6370	ascorbate recycling (cytosolic)	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
HUMAN_PWY-6608	guanosine nucleotides degradation	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
META_PWY-6181	histamine degradation	0.999999999998683	-1.31661478594558e-12	2	0	0	46	907
META_PWY66-368	ketolysis	0.999999999998785	-1.21517121062423e-12	4	0	0	46	907
META_PWY66-423	fructose 2,6-bisphosphate biosynthesis	0.999999999998785	-1.21517121062423e-12	4	0	0	46	907
HUMAN_PWY6666-2	dopamine degradation	0.999999999998785	-1.21517121062423e-12	4	0	0	46	907
HUMAN_PWY-5046	2-oxoisovalerate decarboxylation to isobutanoyl-CoA	0.999999999998785	-1.21517121062423e-12	4	0	0	46	907
HUMAN_2PHENDEG-PWY	phenylethylamine degradation I	0.999999999998785	-1.21517121062423e-12	4	0	0	46	907
HUMAN_HYDROXYPRODEG-PWY	4-hydroxyproline degradation	0.999999999998785	-1.21517121062423e-12	4	0	0	46	907
META_PWY-6405	Rapoport-Luebering glycolytic shunt	0.999999999998785	-1.21517121062423e-12	4	0	0	46	907
META_PWY-7205	CMP phosphorylation	0.999999999998785	-1.21517121062423e-12	4	0	0	46	907
HUMAN_PWY-6117	spermine and spermidine degradation I	0.999999999998785	-1.21517121062423e-12	4	0	0	46	907
HUMAN_PWY-6158	creatine-phosphate biosynthesis	0.999999999998785	-1.21517121062423e-12	4	0	0	46	907
HUMAN_PWY-4361	S-methyl-5-thio-alpha-D-ribose 1-phosphate degradation	0.999999999998785	-1.21517121062423e-12	4	0	0	46	907
META_PWY-3781	aerobic respiration I (cytochrome c)	0.999999999998785	-1.21517121062423e-12	4	0	0	46	907
META_PWY-5046	2-oxoisovalerate decarboxylation to isobutanoyl-CoA	0.999999999998785	-1.21517121062423e-12	4	0	0	46	907
HUMAN_PWY66-368	ketolysis	0.999999999998785	-1.21517121062423e-12	4	0	0	46	907
META_PYRUVDEHYD-PWY	pyruvate decarboxylation to acetyl CoA	0.999999999998785	-1.21517121062423e-12	4	0	0	46	907
HUMAN_PWY-6568	dermatan sulfate biosynthesis (late stages)	0.999999999998785	-1.21517121062423e-12	4	0	0	46	907
META_PWY66-21	ethanol degradation II	0.999999999998785	-1.21517121062423e-12	4	0	0	46	907
HUMAN_PWY-5177	glutaryl-CoA degradation	0.999999999998785	-1.21517121062423e-12	4	0	0	46	907
HUMAN_PWY-5659	GDP-mannose biosynthesis	0.999999999998785	-1.21517121062423e-12	4	0	0	46	907
HUMAN_PWY-7177	UTP and CTP dephosphorylation II	0.999999999998785	-1.21517121062423e-12	4	0	0	46	907
HUMAN_PWY-6292	cysteine biosynthesis	0.999999999998785	-1.21517121062423e-12	4	0	0	46	907
META_PWY-6158	creatine-phosphate biosynthesis	0.999999999998785	-1.21517121062423e-12	4	0	0	46	907
HUMAN_ASPARAGINE-DEG1-PWY-1	asparagine degradation	0.999999999998785	-1.21517121062423e-12	4	0	0	46	907
META_PWY-5067	glycogen biosynthesis II (from UDP-D-Glucose)	0.999999999998785	-1.21517121062423e-12	4	0	0	46	907
HUMAN_PWY66-367	ketogenesis	0.999999999998785	-1.21517121062423e-12	4	0	0	46	907
META_HYDROXYPRODEG-PWY	trans-4-hydroxy-L-proline degradation I	0.999999999998785	-1.21517121062423e-12	4	0	0	46	907
HUMAN_PWY-6755	S-methyl-5-thio-alpha-D-ribose 1-phosphate degradation	0.999999999998785	-1.21517121062423e-12	4	0	0	46	907
META_PWY66-162	ethanol degradation IV	0.999999999998785	-1.21517121062423e-12	4	0	0	46	907
META_PWY-5653	NAD biosynthesis from 2-amino-3-carboxymuconate semialdehyde	0.999999999998785	-1.21517121062423e-12	4	0	0	46	907
META_PWY-6318	L-phenylalanine degradation IV (mammalian, via side chain)	0.999999999998785	-1.21517121062423e-12	4	0	0	46	907
HUMAN_PWY-4921	protein citrullination	0.999999999998785	-1.21517121062423e-12	4	0	0	46	907
HUMAN_PWY66-423	fructose 2,6-bisphosphate synthesis	0.999999999998785	-1.21517121062423e-12	4	0	0	46	907
META_PWY-6608	guanosine nucleotides degradation III	0.999999999998785	-1.21517121062423e-12	4	0	0	46	907
HUMAN_MALATE-ASPARTATE-SHUTTLE-PWY	malate-aspartate shuttle	0.999999999998785	-1.21517121062423e-12	4	0	0	46	907
HUMAN_PWY-5653	NAD biosynthesis from 2-amino-3-carboxymuconate semialdehyde	0.999999999998785	-1.21517121062423e-12	4	0	0	46	907
META_PWY66-161	oxidative ethanol degradation III	0.999999999998785	-1.21517121062423e-12	4	0	0	46	907
META_PWY-5661	GDP-glucose biosynthesis	0.999999999998785	-1.21517121062423e-12	4	0	0	46	907
HUMAN_PWY66-387	fatty acid alpha-oxidation	0.999999999998785	-1.21517121062423e-12	4	0	0	46	907
META_PWY-6061	bile acid biosynthesis, neutral pathway	0.999999999998785	-1.21517121062423e-12	4	0	0	46	907
HUMAN_PWY-4984	urea cycle	0.999999999998785	-1.21517121062423e-12	4	0	0	46	907
META_PWY-6568	dermatan sulfate biosynthesis (late stages)	0.999999999998785	-1.21517121062423e-12	4	0	0	46	907
HUMAN_PWY-5661-1	GDP-glucose biosynthesis II	0.999999999998785	-1.21517121062423e-12	4	0	0	46	907
HUMAN_PWY-5872	ubiquinol-10 biosynthesis	0.999999999998785	-1.21517121062423e-12	4	0	0	46	907
HUMAN_PWY-7112	4-hydroxy-2-nonenal detoxification	0.999999999998785	-1.21517121062423e-12	4	0	0	46	907
HUMAN_PWY-6307	tryptophan degradation via tryptamine	0.999999999998785	-1.21517121062423e-12	4	0	0	46	907
META_PWY-5872	ubiquinol-10 biosynthesis (eukaryotic)	0.999999999998785	-1.21517121062423e-12	4	0	0	46	907
HUMAN_THIOREDOX-PWY	thioredoxin pathway	0.999999999998785	-1.21517121062423e-12	4	0	0	46	907
META_PWY-5994	palmitate biosynthesis I (animals and fungi)	0.999999999998785	-1.21517121062423e-12	4	0	0	46	907
HUMAN_PWY-6517	N-acetylglucosamine degradation II	0.999999999998785	-1.21517121062423e-12	4	0	0	46	907
HUMAN_PWY-4261	glycerol degradation	0.999999999998785	-1.21517121062423e-12	4	0	0	46	907
HUMAN_PWY-6261	thyroid hormone metabolism II (via conjugation and/or degradation)	0.999999999998785	-1.21517121062423e-12	4	0	0	46	907
META_PWY66-387	fatty acid alpha-oxidation II	0.999999999998785	-1.21517121062423e-12	4	0	0	46	907
HUMAN_PWY66-380	estradiol biosynthesis I	0.999999999999442	-5.5767305471804e-13	5	0	0	46	907
HUMAN_PWY-4983	citrulline-nitric oxide cycle	0.999999999999442	-5.5767305471804e-13	5	0	0	46	907
META_PWY-6030	serotonin and melatonin biosynthesis	0.999999999999442	-5.5767305471804e-13	5	0	0	46	907
META_PWY-7226	guanosine deoxyribonucleotides de novo biosynthesis I	0.999999999999442	-5.5767305471804e-13	5	0	0	46	907
META_PWY-7199	pyrimidine deoxyribonucleosides salvage	0.999999999999442	-5.5767305471804e-13	5	0	0	46	907
META_PWY-7433	mucin core 1 and core 2 O-glycosylation	0.999999999999442	-5.5767305471804e-13	5	0	0	46	907
META_PWY-6566	chondroitin biosynthesis	0.999999999999442	-5.5767305471804e-13	5	0	0	46	907
HUMAN_PWY-6566	chondroitin and dermatan biosynthesis	0.999999999999442	-5.5767305471804e-13	5	0	0	46	907
HUMAN_COA-PWY-1	coenzyme A biosynthesis	0.999999999999442	-5.5767305471804e-13	5	0	0	46	907
HUMAN_PWY-7180	2'-deoxy-alpha-D-ribose 1-phosphate degradation	0.999999999999442	-5.5767305471804e-13	5	0	0	46	907
META_PWY-6111	mitochondrial L-carnitine shuttle	0.999999999999442	-5.5767305471804e-13	5	0	0	46	907
HUMAN_PWY-6030	serotonin and melatonin biosynthesis	0.999999999999442	-5.5767305471804e-13	5	0	0	46	907
META_TYRFUMCAT-PWY	L-tyrosine degradation I	0.999999999999442	-5.5767305471804e-13	5	0	0	46	907
META_PWY66-367	ketogenesis	0.999999999999442	-5.5767305471804e-13	5	0	0	46	907
HUMAN_PWY4FS-6	phosphatidylethanolamine biosynthesis II	0.999999999999442	-5.5767305471804e-13	5	0	0	46	907
META_PWY-6313	serotonin degradation	0.999999999999442	-5.5767305471804e-13	5	0	0	46	907
HUMAN_TYRFUMCAT-PWY	tyrosine degradation	0.999999999999442	-5.5767305471804e-13	5	0	0	46	907
HUMAN_PYRUVDEHYD-PWY	pyruvate decarboxylation to acetyl CoA	0.999999999999442	-5.5767305471804e-13	5	0	0	46	907
META_PWY-6074	zymosterol biosynthesis	0.999999999999442	-5.5767305471804e-13	5	0	0	46	907
META_PWY-6398	melatonin degradation I	0.999999999999442	-5.5767305471804e-13	5	0	0	46	907
META_PWY-4983	L-citrulline-nitric oxide cycle	0.999999999999442	-5.5767305471804e-13	5	0	0	46	907
META_PWY-5651	L-tryptophan degradation to 2-amino-3-carboxymuconate semialdehyde	0.999999999999442	-5.5767305471804e-13	5	0	0	46	907
META_VALDEG-PWY	L-valine degradation I	0.999999999999442	-5.5767305471804e-13	5	0	0	46	907
META_PWY-6402	superpathway of melatonin degradation	0.999999999999442	-5.5767305471804e-13	5	0	0	46	907
META_PWY66-201	nicotine degradation IV	0.999999999999442	-5.5767305471804e-13	5	0	0	46	907
HUMAN_PWY66-21	ethanol degradation II	0.999999999999442	-5.5767305471804e-13	5	0	0	46	907
HUMAN_PWY66-162	ethanol degradation IV	0.999999999999442	-5.5767305471804e-13	5	0	0	46	907
HUMAN_PLPSAL-PWY	pyridoxal 5'-phosphate salvage	0.999999999999442	-5.5767305471804e-13	5	0	0	46	907
META_PWY-4061	glutathione-mediated detoxification I	0.999999999999442	-5.5767305471804e-13	5	0	0	46	907
HUMAN_PWY66-241	bupropion degradation	0.999999999999442	-5.5767305471804e-13	5	0	0	46	907
HUMAN_PWY66-422	D-galactose degradation V (Leloir pathway)	0.999999999999442	-5.5767305471804e-13	5	0	0	46	907
HUMAN_UDPNACETYLGALSYN-PWY	UDP-N-acetyl-D-glucosamine biosynthesis II	0.999999999999442	-5.5767305471804e-13	5	0	0	46	907
META_COA-PWY-1	coenzyme A biosynthesis II (mammalian)	0.999999999999442	-5.5767305471804e-13	5	0	0	46	907
META_PWY-6261	thyroid hormone metabolism II (via conjugation and/or degradation)	0.999999999999442	-5.5767305471804e-13	5	0	0	46	907
META_PWY-7227	adenosine deoxyribonucleotides de novo biosynthesis	0.999999999999442	-5.5767305471804e-13	5	0	0	46	907
HUMAN_PWY-7199	pyrimidine deoxyribonucleosides salvage	0.999999999999442	-5.5767305471804e-13	5	0	0	46	907
HUMAN_PWY-5030	histidine degradation	0.999999999999442	-5.5767305471804e-13	5	0	0	46	907
META_PWY-4921	protein citrullination	0.999999999999442	-5.5767305471804e-13	5	0	0	46	907
META_PWY-4984	urea cycle	0.999999999999442	-5.5767305471804e-13	5	0	0	46	907
HUMAN_PWY-6111	mitochondrial L-carnitine shuttle	0.999999999999442	-5.5767305471804e-13	5	0	0	46	907
META_PWY-7197	pyrimidine deoxyribonucleotide phosphorylation	0.999999999999442	-5.5767305471804e-13	5	0	0	46	907
META_PWY-4081	glutathione redox reactions I	0.999999999999442	-5.5767305471804e-13	5	0	0	46	907
HUMAN_PWY-5966-1	fatty acid biosynthesis initiation	0.999999999999442	-5.5767305471804e-13	5	0	0	46	907
HUMAN_PWY3DJ-12	ceramide de novo biosynthesis	0.999999999999937	-6.27669499855571e-14	6	0	0	46	907
META_PWY66-428	L-threonine degradation V	0.999999999999937	-6.27669499855571e-14	6	0	0	46	907
META_PWY-5972	stearate biosynthesis I (animals and fungi)	0.999999999999937	-6.27669499855571e-14	6	0	0	46	907
META_PWY66-373	sucrose degradation V (sucrose alpha-glucosidase)	0.999999999999937	-6.27669499855571e-14	6	0	0	46	907
META_PWY-6342	noradrenaline and adrenaline degradation	0.999999999999937	-6.27669499855571e-14	6	0	0	46	907
HUMAN_PWY3O-450	phosphatidylcholine biosynthesis	0.999999999999937	-6.27669499855571e-14	6	0	0	46	907
META_PWY66-378	androgen biosynthesis	0.999999999999937	-6.27669499855571e-14	6	0	0	46	907
HUMAN_PWY-5143	fatty acid activation	0.999999999999937	-6.27669499855571e-14	6	0	0	46	907
META_PWY3DJ-12	ceramide de novo biosynthesis	0.999999999999937	-6.27669499855571e-14	6	0	0	46	907
HUMAN_PWY-6557	glycoaminoglycan-protein linkage region biosynthesis	0.999999999999937	-6.27669499855571e-14	6	0	0	46	907
META_PWY-7229	superpathway of adenosine nucleotides de novo biosynthesis I	0.999999999999937	-6.27669499855571e-14	6	0	0	46	907
META_ILEUDEG-PWY	L-isoleucine degradation I	0.999999999999937	-6.27669499855571e-14	6	0	0	46	907
HUMAN_PWY-5996	oleate biosynthesis	0.999999999999937	-6.27669499855571e-14	6	0	0	46	907
HUMAN_PWY-6074	zymosterol biosynthesis	0.999999999999937	-6.27669499855571e-14	6	0	0	46	907
HUMAN_PWY66-161	oxidative ethanol degradation III	0.999999999999937	-6.27669499855571e-14	6	0	0	46	907
HUMAN_PWY66-378	androgen biosynthesis	0.999999999999937	-6.27669499855571e-14	6	0	0	46	907
META_PWY-7176	UTP and CTP de novo biosynthesis	0.999999999999937	-6.27669499855571e-14	6	0	0	46	907
HUMAN_PWY-7455	allopregnanolone biosynthesis	0.999999999999937	-6.27669499855571e-14	6	0	0	46	907
META_PWY-7455	allopregnanolone biosynthesis	0.999999999999937	-6.27669499855571e-14	6	0	0	46	907
HUMAN_PWY-4081	glutathione redox reactions I	0.999999999999937	-6.27669499855571e-14	6	0	0	46	907
META_PWY-7277	sphingolipid biosynthesis (mammals)	0.999999999999937	-6.27669499855571e-14	6	0	0	46	907
HUMAN_PWY66-428	threonine degradation	0.999999999999937	-6.27669499855571e-14	6	0	0	46	907
META_PWY-5327	superpathway of L-lysine degradation	0.999999999999937	-6.27669499855571e-14	6	0	0	46	907
META_PWY-6557	glycoaminoglycan-protein linkage region biosynthesis	0.999999999999937	-6.27669499855571e-14	6	0	0	46	907
META_PWY-6756	S-methyl-5'-thioadenosine degradation II	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
META_PWY-7625	phosphatidylinositol biosynthesis II (eukaryotes)	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
META_PWY-6292	superpathway of L-cysteine biosynthesis (mammalian)	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
HUMAN_PWY-6133	(S)-reticuline biosynthesis	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
META_PWY66-421	homocarnosine biosynthesis	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
META_PWY-5329	L-cysteine degradation III	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
META_ASPARTATESYN-PWY	L-aspartate biosynthesis	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
META_PWY-6273	phosphatidylethanolamine biosynthesis III	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
META_PWY-5686	UMP biosynthesis	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
META_ALANINE-SYN2-PWY	L-alanine biosynthesis II	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
HUMAN_PWY-5148	acyl-CoA hydrolysis	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
HUMAN_PWY-6399	melatonin degradation II	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
HUMAN_GLYCGREAT-PWY	creatine biosynthesis	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
META_PWY-7250	[2Fe-2S] iron-sulfur cluster biosynthesis	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
META_PWY-5905	hypusine biosynthesis	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
HUMAN_PWY-7506	phosphatidylserine biosynthesis II	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
META_PWY-5966	fatty acid biosynthesis initiation II	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
HUMAN_PWY-6898	thiamin salvage III	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
META_PWY-5512	UDP-N-acetyl-D-galactosamine biosynthesis I	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
HUMAN_PWY-5652	2-amino-3-carboxymuconate semialdehyde degradation to glutaryl-CoA	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
HUMAN_PWY-6132	lanosterol biosynthesis	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
HUMAN_PWY0-522	lipoate salvage	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
HUMAN_PWY-5120	geranylgeranyldiphosphate biosynthesis	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
META_PWY-6377	alpha-tocopherol degradation	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
META_GLYCGREAT-PWY	creatine biosynthesis	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
META_PWY-5326	sulfite oxidation IV	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
META_GLUT-REDOX-PWY	glutathione redox reactions II	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
META_PWY66-389	phytol degradation	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
HUMAN_PWY-5754	4-hydroxybenzoate biosynthesis	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
HUMAN_BGALACT-PWY	lactose degradation III	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
HUMAN_PWY-40	putrescine biosynthesis II	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
HUMAN_PWY-5512	UDP-N-acetyl-D-galactosamine biosynthesis I	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
META_PWY-7506	phosphatidylserine biosynthesis II	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
META_PWY-6012-1	acyl carrier protein metabolism II (mammalian)	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
META_PWY-6938	NADH repair	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
HUMAN_PROUT-PWY	proline degradation	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
META_PWY-6502	oxidized GTP and dGTP detoxification	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
HUMAN_ARGSPECAT-PWY	spermine biosynthesis	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
META_PWY-7219	adenosine ribonucleotides de novo biosynthesis	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
META_PWY-5120	geranylgeranyl diphosphate biosynthesis	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
META_PWY-7299	progesterone biosynthesis	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
HUMAN_PWY-7592	arachidonate biosynthesis III (metazoa)	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
HUMAN_HOMOCYSDEGR-PWY	cysteine biosynthesis/homocysteine degradation (trans-sulfuration)	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
META_PWY-5754	4-hydroxybenzoate biosynthesis I (eukaryotes)	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
HUMAN_PWY-5326	sulfite oxidation	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
HUMAN_PWY0-1305	glutamate dependent acid resistance	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
META_GLNSYN-PWY	L-glutamine biosynthesis I	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
HUMAN_PWY-4101	sorbitol degradation I	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
HUMAN_SERDEG-PWY	L-serine degradation	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
META_PWY-7112	4-hydroxy-2-nonenal detoxification	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
META_PWY-40	putrescine biosynthesis I	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
META_PWY-7306	estradiol biosynthesis II	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
HUMAN_PWY-7299	progesterone biosynthesis	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
HUMAN_PWY66-421	homocarnosine biosynthesis	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
META_PWY-7592	arachidonate biosynthesis III (metazoa)	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
META_PWY-5766	L-glutamate degradation X	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
HUMAN_PWY-6173	histamine biosynthesis	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
HUMAN_PWY-6756	S-methyl-5'-thioadenosine degradation	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
META_PWY66-241	bupropion degradation	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
HUMAN_GLUTAMATE-SYN2-PWY	glutamate biosynthesis/degradation	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
HUMAN_PWY66-420	carnosine biosynthesis	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
META_PWY-7344	UDP-D-galactose biosynthesis	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
META_GLUTAMATE-SYN2-PWY	L-glutamate biosynthesis II	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
META_HISHP-PWY	L-histidine degradation VI	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
META_ARGSPECAT-PWY	spermine biosynthesis	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
META_ALANINE-DEG3-PWY	L-alanine degradation III	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
HUMAN_PWY-6938	NADH repair	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
HUMAN_NADPHOS-DEPHOS-PWY-1	NAD phosphorylation and dephosphorylation	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
META_PWY-7501	phosphatidylserine biosynthesis I	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
META_PWY-6132	lanosterol biosynthesis	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
HUMAN_PWY66-426	hydrogen sulfide biosynthesis (trans-sulfuration)	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
META_PWY6666-1	anandamide degradation	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
META_PWY66-420	carnosine biosynthesis	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
META_PWY-5652	2-amino-3-carboxymuconate semialdehyde degradation to glutaryl-CoA	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
HUMAN_MANNCAT-PWY	D-mannose degradation	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
HUMAN_PWY-6535	4-aminobutyrate degradation	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
HUMAN_PWY-66	GDP-L-fucose biosynthesis I (from GDP-D-mannose)	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
META_PWY-5172	acetyl-CoA biosynthesis III (from citrate)	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
META_PWY-6173	histamine biosynthesis	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
HUMAN_PWY-7250	[2Fe-2S] iron-sulfur cluster biosynthesis	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
META_PWY-6481	L-dopachrome biosynthesis	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
HUMAN_PWY-7501	phosphatidylserine biosynthesis I	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
HUMAN_PWY-5329	L-cysteine degradation II	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
HUMAN_GLUT-REDOX-PWY	glutathione redox reactions II	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
META_MGLDLCTANA-PWY	methylglyoxal degradation VI	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
HUMAN_PWY-5963	thio-molybdenum cofactor biosynthesis	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
HUMAN_PWY-6502	oxidized GTP and dGTP detoxification	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
META_PWY-5886	4-hydroxyphenylpyruvate biosynthesis	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
META_PWY0-1313	acetate conversion to acetyl-CoA	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
HUMAN_PWY-6377	alpha-tocopherol degradation	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
META_PWY0-1021	L-alanine biosynthesis III	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
HUMAN_ALANINE-DEG3-PWY	alanine biosynthesis/degradation	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
HUMAN_SERSYN-PWY	serine biosynthesis (phosphorylated route)	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
META_PWY-6134	L-tyrosine biosynthesis IV	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
META_NADPHOS-DEPHOS-PWY-1	NAD phosphorylation and dephosphorylation II (mammalian)	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
HUMAN_GLNSYN-PWY	glutamine biosynthesis	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
META_PWY-5269	cardiolipin biosynthesis II	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
HUMAN_PWY-5172	acetyl-CoA biosynthesis from citrate	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
HUMAN_PWY66-389	phytol degradation	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
HUMAN_PWY-6481	L-dopachrome biosynthesis	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
META_PWY-7435	mucin core 3 and core 4 O-glycosylation	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
META_PWY-6241	thyroid hormone biosynthesis	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
META_PWY-4361	S-methyl-5-thio-alpha-D-ribose 1-phosphate degradation	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
META_PWY-6535	4-aminobutanoate degradation I	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
HUMAN_MGLDLCTANA-PWY	methylglyoxal degradation VI	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
HUMAN_PWY-6334	L-dopa degradation	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
HUMAN_PWY66-11	BMP Signalling Pathway	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
HUMAN_PWY-2161B	glutamate removal from folates	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
META_PWY-6133	(S)-reticuline biosynthesis II	1.00000000000024	2.43631503860087e-13	1	0	0	46	907
META_PWY66-382	mineralocorticoid biosynthesis	1.00000000000032	3.15521588890866e-13	3	0	0	46	907
HUMAN_PROPIONMET-PWY	propionyl-CoA degradation	1.00000000000032	3.15521588890866e-13	3	0	0	46	907
META_ADENOSYLHOMOCYSCAT-PWY	L-methionine salvage from L-homocysteine	1.00000000000032	3.15521588890866e-13	3	0	0	46	907
META_PWY-5996	oleate biosynthesis II (animals and fungi)	1.00000000000032	3.15521588890866e-13	3	0	0	46	907
HUMAN_PWY-5331	taurine biosynthesis	1.00000000000032	3.15521588890866e-13	3	0	0	46	907
META_PWY-5664	tetrahydrobiopterin biosynthesis II	1.00000000000032	3.15521588890866e-13	3	0	0	46	907
HUMAN_PWY-7193	pyrimidine ribonucleosides salvage I	1.00000000000032	3.15521588890866e-13	3	0	0	46	907
META_PROPIONMET-PWY	propanoyl CoA degradation I	1.00000000000032	3.15521588890866e-13	3	0	0	46	907
HUMAN_PWY66-381	glucocorticoid biosynthesis	1.00000000000032	3.15521588890866e-13	3	0	0	46	907
META_PWY-5084	2-oxoglutarate decarboxylation to succinyl-CoA	1.00000000000032	3.15521588890866e-13	3	0	0	46	907
META_PWY-5331	taurine biosynthesis	1.00000000000032	3.15521588890866e-13	3	0	0	46	907
HUMAN_PWY-6366	D-myo-inositol (1,4,5,6)-tetrakisphosphate biosynthesis	1.00000000000032	3.15521588890866e-13	3	0	0	46	907
HUMAN_PWY66-388	fatty acid alpha-oxidation III	1.00000000000032	3.15521588890866e-13	3	0	0	46	907
META_ASPARAGINE-DEG1-PWY-1	L-asparagine degradation III (mammalian)	1.00000000000032	3.15521588890866e-13	3	0	0	46	907
META_PWY-6000	gamma-linolenate biosynthesis II (animals)	1.00000000000032	3.15521588890866e-13	3	0	0	46	907
META_PWY-7606	docosahexaenoate biosynthesis III (mammals)	1.00000000000032	3.15521588890866e-13	3	0	0	46	907
META_MALATE-ASPARTATE-SHUTTLE-PWY	L-aspartate degradation II	1.00000000000032	3.15521588890866e-13	3	0	0	46	907
HUMAN_PWY-4202	arsenate detoxification I (glutaredoxin)	1.00000000000032	3.15521588890866e-13	3	0	0	46	907
META_GLYCLEAV-PWY	glycine cleavage	1.00000000000032	3.15521588890866e-13	3	0	0	46	907
META_PWY66-392	lipoxin biosynthesis	1.00000000000032	3.15521588890866e-13	3	0	0	46	907
META_PWY6666-2	dopamine degradation	1.00000000000032	3.15521588890866e-13	3	0	0	46	907
HUMAN_PWY66-382	mineralocorticoid biosynthesis	1.00000000000032	3.15521588890866e-13	3	0	0	46	907
HUMAN_ADENOSYLHOMOCYSCAT-PWY	methionine salvage	1.00000000000032	3.15521588890866e-13	3	0	0	46	907
HUMAN_PWY-6430	thymine degradation	1.00000000000032	3.15521588890866e-13	3	0	0	46	907
META_PWY66-381	glucocorticoid biosynthesis	1.00000000000032	3.15521588890866e-13	3	0	0	46	907
META_PWY66-301	catecholamine biosynthesis	1.00000000000032	3.15521588890866e-13	3	0	0	46	907
HUMAN_PWY-6100	L-carnitine biosynthesis	1.00000000000032	3.15521588890866e-13	3	0	0	46	907
HUMAN_PWY-5084	2-oxoglutarate decarboxylation to succinyl-CoA	1.00000000000032	3.15521588890866e-13	3	0	0	46	907
HUMAN_PWY-7185	UTP and CTP dephosphorylation I	1.00000000000032	3.15521588890866e-13	3	0	0	46	907
META_PWY-6366	D-myo-inositol (1,4,5,6)-tetrakisphosphate biosynthesis	1.00000000000032	3.15521588890866e-13	3	0	0	46	907
META_PWY0-1296	purine ribonucleosides degradation	1.00000000000032	3.15521588890866e-13	3	0	0	46	907
META_ARGASEDEG-PWY	L-arginine degradation I (arginase pathway)	1.00000000000032	3.15521588890866e-13	3	0	0	46	907
HUMAN_PWY-3982	uracil degradation	1.00000000000032	3.15521588890866e-13	3	0	0	46	907
HUMAN_METHIONINE-DEG1-PWY	methionine degradation	1.00000000000032	3.15521588890866e-13	3	0	0	46	907
META_PWY-0	putrescine degradation III	1.00000000000032	3.15521588890866e-13	3	0	0	46	907
HUMAN_PWY-6554	1D-myo-inositol hexakisphosphate biosynthesis V (from Ins(1,3,4)P3)	1.00000000000032	3.15521588890866e-13	3	0	0	46	907
HUMAN_PWY0-1182	trehalose degradation	1.00000000000032	3.15521588890866e-13	3	0	0	46	907
META_PWY-6100	L-carnitine biosynthesis	1.00000000000032	3.15521588890866e-13	3	0	0	46	907
META_PWY-5451	acetone degradation I (to methylglyoxal)	1.00000000000032	3.15521588890866e-13	3	0	0	46	907
META_PWY-5663	tetrahydrobiopterin biosynthesis I	1.00000000000032	3.15521588890866e-13	3	0	0	46	907
HUMAN_NAD-BIOSYNTHESIS-III	NAD salvage	1.00000000000032	3.15521588890866e-13	3	0	0	46	907
HUMAN_PWY-5663	tetrahydrobiopterin de novo biosynthesis	1.00000000000032	3.15521588890866e-13	3	0	0	46	907
META_PWY-2301	myo-inositol biosynthesis	1.00000000000032	3.15521588890866e-13	3	0	0	46	907
META_PHENYLALANINE-DEG1-PWY	L-phenylalanine degradation I (aerobic)	1.00000000000032	3.15521588890866e-13	3	0	0	46	907
META_PWY-7193	pyrimidine ribonucleosides salvage I	1.00000000000032	3.15521588890866e-13	3	0	0	46	907
META_PWY-7177	UTP and CTP dephosphorylation II	1.00000000000032	3.15521588890866e-13	3	0	0	46	907
META_HEME-BIOSYNTHESIS-II	heme biosynthesis I (aerobic)	1.00000000000032	3.15521588890866e-13	3	0	0	46	907
META_PWY-7049	icosapentaenoate biosynthesis II (metazoa)	1.00000000000032	3.15521588890866e-13	3	0	0	46	907
HUMAN_NONOXIPENT-PWY	pentose phosphate pathway (non-oxidative branch)	1.00000000000032	3.15521588890866e-13	3	0	0	46	907
HUMAN_GLUAMCAT-PWY	N-acetylglucosamine degradation I	1.00000000000032	3.15521588890866e-13	3	0	0	46	907
META_PWY-4202	arsenate detoxification I (glutaredoxin)	1.00000000000032	3.15521588890866e-13	3	0	0	46	907
HUMAN_PWY0-1296	purine ribonucleosides degradation to ribose-1-phosphate	1.00000000000032	3.15521588890866e-13	3	0	0	46	907
META_PWY-3982	uracil degradation I (reductive)	1.00000000000032	3.15521588890866e-13	3	0	0	46	907
HUMAN_GLYCLEAV-PWY	glycine cleavage	1.00000000000032	3.15521588890866e-13	3	0	0	46	907
META_PWY-7466	acetone degradation III (to propane-1,2-diol)	1.00000000000032	3.15521588890866e-13	3	0	0	46	907
HUMAN_HEME-BIOSYNTHESIS-II	heme biosynthesis from uroporphyrinogen-III I	1.00000000000032	3.15521588890866e-13	3	0	0	46	907
HUMAN_GLUDEG-I-PWY	GABA shunt	1.00000000000032	3.15521588890866e-13	3	0	0	46	907
HUMAN_PHENYLALANINE-DEG1-PWY	phenylalanine degradation/tyrosine biosynthesis	1.00000000000032	3.15521588890866e-13	3	0	0	46	907
HUMAN_SAM-PWY	S-adenosyl-L-methionine biosynthesis	1.00000000000032	3.15521588890866e-13	3	0	0	46	907
HUMAN_PWY-5453	methylglyoxal degradation III	1.00000000000032	3.15521588890866e-13	3	0	0	46	907
META_GLYCINE-SYN2-PWY	glycine biosynthesis II	1.00000000000032	3.15521588890866e-13	3	0	0	46	907
META_PWY66-221	nicotine degradation V	1.00000000000032	3.15521588890866e-13	3	0	0	46	907
HUMAN_PWY66-392	lipoxin biosynthesis	1.00000000000032	3.15521588890866e-13	3	0	0	46	907
HUMAN_PWY-7606	docosahexaenoate biosynthesis III (mammals)	1.00000000000032	3.15521588890866e-13	3	0	0	46	907
META_PWY-7185	UTP and CTP dephosphorylation I	1.00000000000032	3.15521588890866e-13	3	0	0	46	907
META_PWY66-422	D-galactose degradation V (Leloir pathway)	1.00000000000032	3.15521588890866e-13	3	0	0	46	907
HUMAN_TRYPTOPHAN-DEGRADATION-1	tryptophan degradation	1.00000000000083	8.25233956548865e-13	8	0	0	46	907
META_PWY-7426	mannosyl-glycoprotein N-acetylglucosaminyltransferases	1.00000000000083	8.25233956548865e-13	8	0	0	46	907
META_TRYPTOPHAN-DEGRADATION-1	L-tryptophan degradation III (eukaryotic)	1.00000000000083	8.25233956548865e-13	8	0	0	46	907
HUMAN_PWY-5451	acetone degradation I (to methylglyoxal)	1.00000000000083	8.25233956548865e-13	8	0	0	46	907
HUMAN_PWY-5514	UDP-N-acetyl-D-galactosamine biosynthesis II	1.00000000000083	8.25233956548865e-13	8	0	0	46	907
HUMAN_PWY3DJ-11281	sphingomyelin metabolism/ceramide salvage	1.00000000000098	9.778085957177e-13	7	0	0	46	907
META_LEU-DEG2-PWY	L-leucine degradation I	1.00000000000098	9.778085957177e-13	7	0	0	46	907
META_PWY0-162	superpathway of pyrimidine ribonucleotides de novo biosynthesis	1.00000000000098	9.778085957177e-13	7	0	0	46	907
HUMAN_PWY-5651	tryptophan degradation to 2-amino-3-carboxymuconate semialdehyde	1.00000000000098	9.778085957177e-13	7	0	0	46	907
HUMAN_PWY66-221	nicotine degradation III	1.00000000000098	9.778085957177e-13	7	0	0	46	907
META_PWY-7224	purine deoxyribonucleosides salvage	1.00000000000098	9.778085957177e-13	7	0	0	46	907
HUMAN_PWY-5994	palmitate biosynthesis	1.00000000000098	9.778085957177e-13	7	0	0	46	907
META_PWY-6567	chondroitin sulfate biosynthesis (late stages)	1.00000000000098	9.778085957177e-13	7	0	0	46	907
HUMAN_PWY-6369	inositol pyrophosphates biosynthesis	1.00000000000098	9.778085957177e-13	7	0	0	46	907
META_PWY-5130	2-oxobutanoate degradation I	1.00000000000098	9.778085957177e-13	7	0	0	46	907
HUMAN_PWY66-373	sucrose degradation	1.00000000000098	9.778085957177e-13	7	0	0	46	907
HUMAN_PWY-5067	glycogen biosynthesis	1.00000000000098	9.778085957177e-13	7	0	0	46	907
META_PWY-6369	inositol pyrophosphates biosynthesis	1.00000000000098	9.778085957177e-13	7	0	0	46	907
HUMAN_PWY-6313	serotonin degradation	1.00000000000098	9.778085957177e-13	7	0	0	46	907
META_DETOX1-PWY-1	reactive oxygen species degradation	1.00000000000098	9.778085957177e-13	7	0	0	46	907
HUMAN_PWY-5130	2-oxobutanoate degradation	1.00000000000098	9.778085957177e-13	7	0	0	46	907
HUMAN_MANNOSYL-CHITO-DOLICHOL-BIOSYNTHESIS	dolichyl-diphosphooligosaccharide biosynthesis	1.00000000000192	1.92014778049088e-12	9	0	0	46	907
META_PWY-7210	pyrimidine deoxyribonucleotides biosynthesis from CTP	1.00000000000192	1.92014778049088e-12	9	0	0	46	907
META_NADSYN-PWY	NAD biosynthesis II (from tryptophan)	1.00000000000192	1.92014778049088e-12	9	0	0	46	907
META_PWY-6309	L-tryptophan degradation XI (mammalian, via kynurenine)	1.00000000000192	1.92014778049088e-12	9	0	0	46	907
HUMAN_PWY-0	putrescine degradation III	1.00000000000192	1.92014778049088e-12	9	0	0	46	907
HUMAN_PWY3DJ-11470	sphingosine and sphingosine-1-phosphate metabolism	1.00000000000192	1.92014778049088e-12	9	0	0	46	907
META_PWY-7184	pyrimidine deoxyribonucleotides de novo biosynthesis I	1.00000000000192	1.92014778049088e-12	9	0	0	46	907
META_PWY-7305	superpathway of steroid hormone biosynthesis	1.0000000000027	2.69758285811915e-12	11	0	0	46	907
HUMAN_PWY-6309	L-kynurenine degradation	1.0000000000027	2.69758285811915e-12	11	0	0	46	907
HUMAN_PWY-5972	stearate biosynthesis	1.0000000000027	2.69758285811915e-12	11	0	0	46	907
HUMAN_LEU-DEG2-PWY	leucine degradation	1.0000000000027	2.69758285811915e-12	11	0	0	46	907
HUMAN_PWY-6402	superpathway of melatonin degradation	1.0000000000027	2.69758285811915e-12	11	0	0	46	907
HUMAN_NADSYN-PWY	NAD de novo biosynthesis	1.0000000000027	2.69758285811915e-12	11	0	0	46	907
HUMAN_DETOX1-PWY-1	reactive oxygen species degradation	1.0000000000032	3.2040317518572e-12	10	0	0	46	907
HUMAN_PWY-6342	noradrenaline and adrenaline degradation	1.0000000000032	3.2040317518572e-12	10	0	0	46	907
META_PWY-7200	superpathway of pyrimidine deoxyribonucleoside salvage	1.0000000000032	3.2040317518572e-12	10	0	0	46	907
HUMAN_PWY-6398	melatonin degradation I	1.0000000000032	3.2040317518572e-12	10	0	0	46	907
HUMAN_PWY-7049	icosapentaenoate biosynthesis II (metazoa)	1.0000000000032	3.2040317518572e-12	10	0	0	46	907
HUMAN_PWY66-201	nicotine degradation IV	1.0000000000032	3.2040317518572e-12	10	0	0	46	907
HUMAN_VALDEG-PWY	valine degradation	1.00000000000353	3.53401008861968e-12	12	0	0	46	907
HUMAN_PWY-6061	bile acid biosynthesis, neutral pathway	1.00000000000353	3.53401008861968e-12	12	0	0	46	907
HUMAN_ILEUDEG-PWY	isoleucine degradation	1.00000000000353	3.53401008861968e-12	12	0	0	46	907
HUMAN_PWY-6000	gamma-linolenate biosynthesis	1.00000000000353	3.53401008861968e-12	12	0	0	46	907
META_FAO-PWY	fatty acid beta-oxidation I	1.00000000000402	4.01733280964727e-12	14	0	0	46	907
HUMAN_FAO-PWY	fatty acid beta-oxidation	1.00000000000402	4.01733280964727e-12	14	0	0	46	907
HUMAN_PWY-7305	superpathway of steroid hormone biosynthesis	1.00000000000402	4.01733280964727e-12	14	0	0	46	907
HUMAN_PWY-5328	superpathway of methionine degradation	1.00000000000402	4.01733280964727e-12	14	0	0	46	907
META_PWY-5328	superpathway of L-methionine salvage and degradation	1.00000000000402	4.01733280964727e-12	14	0	0	46	907
HUMAN_PWY-6567	chondroitin sulfate biosynthesis (late stages)	1.00000000000404	4.04174630491016e-12	13	0	0	46	907
META_PWY-7211	superpathway of pyrimidine deoxyribonucleotides de novo biosynthesis	1.00000000000404	4.04174630491016e-12	13	0	0	46	907
HUMAN_PWY66-399	gluconeogenesis	1.0000000000057	5.69620270360622e-12	16	0	0	46	907
META_PWY66-398	TCA cycle III (animals)	1.0000000000057	5.69620270360622e-12	16	0	0	46	907
HUMAN_PWY66-398	TCA cycle	1.0000000000057	5.69620270360622e-12	16	0	0	46	907
META_PWY66-399	gluconeogenesis III	1.0000000000057	5.69620270360622e-12	16	0	0	46	907
META_ANAEROFRUCAT-PWY	homolactic fermentation	1.00000000000578	5.77812667776319e-12	15	0	0	46	907
HUMAN_PWY-6571	dermatan sulfate biosynthesis	1.00000000000578	5.77812667776319e-12	15	0	0	46	907
META_PWY-6571	dermatan sulfate biosynthesis	1.00000000000578	5.77812667776319e-12	15	0	0	46	907
META_PWY66-400	glycolysis VI (metazoan)	1.00000000000664	6.64105201998611e-12	17	0	0	46	907
META_PWY-6558	heparan sulfate biosynthesis (late stages)	1.00000000000664	6.64105201998611e-12	17	0	0	46	907
HUMAN_PWY66-400	glycolysis	1.00000000000664	6.64105201998611e-12	17	0	0	46	907
META_PWY-6569	chondroitin sulfate biosynthesis	1.00000000000742	7.42408538023359e-12	18	0	0	46	907
HUMAN_PWY-6569	chondroitin sulfate biosynthesis	1.00000000000788	7.88333904254626e-12	19	0	0	46	907
HUMAN_PWY-6558	heparan sulfate biosynthesis (late stages)	1.0000000000085	8.50093544158944e-12	20	0	0	46	907
META_PWY-6564	heparan sulfate biosynthesis	1.00000000000887	8.8707723055932e-12	23	0	0	46	907
META_PWY-6352	3-phosphoinositide biosynthesis	1.00000000001065	1.06482254610897e-11	25	0	0	46	907
HUMAN_PWY-6352	3-phosphoinositide biosynthesis	1.00000000001212	1.21249729178691e-11	27	0	0	46	907
HUMAN_PWY-6564	heparan sulfate biosynthesis	1.00000000001229	1.22896873423553e-11	26	0	0	46	907
HUMAN_PWY-7511	protein ubiquitylation	1.00000000001385	1.38491674921265e-11	28	0	0	46	907
HUMAN_PWY66-401	superpathway of tryptophan utilization	1.00000000001602	1.60229277168308e-11	34	0	0	46	907
HUMAN_PWY66-407	superpathway of conversion of glucose to acetyl CoA and entry into the TCA cycle	1.00000000001729	1.72866510513152e-11	38	0	0	46	907
